Weber Syndrome secondary to synthetic cannabinoid use

dc.contributor.author	Karabulut, Sercan
dc.contributor.author	Yargic, Lutfi Ilhan
dc.date.accessioned	2021-03-03T10:39:46Z
dc.date.available	2021-03-03T10:39:46Z
dc.identifier.citation	Karabulut S., Yargic L. I. , "Weber Syndrome secondary to synthetic cannabinoid use", ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, cilt.15, 2014
dc.identifier.issn	1302-6631
dc.identifier.other	vv_1032021
dc.identifier.other	av_23ed1d75-f835-4fd4-90f1-0ab47f4e75ee
dc.identifier.uri	http://hdl.handle.net/20.500.12627/29072
dc.identifier.uri	https://doi.org/10.5455/apd.40640
dc.description.abstract	Synthetic cannabinoid abuse may lead to physical and psychological disorders. This substance has disseminated rapidly in recent years and the literature about its bad consequences is rather sparse. In this study, we aimed to introduce a patient who present with mesencephalon infarctus (Weber Syndrome) after using synthetic cannabinoid.
dc.language.iso	eng
dc.subject	Klinik Tıp (MED)
dc.subject	Psikiyatri
dc.subject	Sağlık Bilimleri
dc.title	Weber Syndrome secondary to synthetic cannabinoid use
dc.type	Makale
dc.relation.journal	ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
dc.contributor.department	İstanbul Üniversitesi , ,
dc.identifier.volume	15
dc.contributor.firstauthorID	213540

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.